Objective: To provide a practical guide for the implementation and use of  Pharmaceutical Care through Telepharmacy by healthcare professionals and  patients in its different scopes of application. To establish a definition of  Telepharmacy and describe the technological tools necessary, advantages, and  keys to facilitating its implementation.

Method: Between December 2020 and January 2021, the Board of Directors of the Spanish Society of Hospital Pharmacy, along with the coordinators of the  project "Outpatient Care Strategies" ("Mapa Estratégico para la Atención al  Paciente Externo") designed a strategy to foster the development and  expansion of Telepharmacy in Spain. This strategy involved four courses of  action. To develop the first course of action, a call was made in March 2021  among the Spanish Society of Hospital Pharmacy members to develop seven  methodological guidelines. The purpose of these documents was to meet the  needs for the implementation of Telepharmacy, the most relevant being the  development of specific guides for professionals and patients. The guides were  developed in four stages between May and October 2021, including a literature review; consensus-based interviews, online workshops, and, finally, the  drafting and validation of the final documents. Once the final draft was  prepared, a public evaluation of suggestions and observations was performed  for a month. The documents were also presented to the Patient Committee of  the Spanish Society of Hospital Pharmacy.

Results: The Guide for Professionals provides guidelines for the development and implementation of Telepharmacy in its different scopes of  application. These guides provide a description of specific goals, healthcare benefits, tools required, and keys to the implementation of  Telepharmacy. The Guide for Patients is complementary to face-to-face  pharmaceutical care from the point of view of the patient, with special  emphasis being placed on the most frequently used tools, the potential  benefits, and the keys to facilitating patients' understanding of the purpose  and use of Telepharmacy.

Conclusions: A Practical Guide for Professionals and Patients was developed to ensure the standard development, implementation, and spread of Telepharmacy in all its scopes. This guide is intended to help Hospital Pharmacy professionals benefit from Telepharmacy as a  complementary tool to face-to-face pharmaceutical care.

Download full-text PDF

Source

Publication Analysis

Top Keywords

pharmaceutical care
12
guide professionals
12
professionals patients
12
spanish society
12
telepharmacy
8
care telepharmacy
8
practical guide
8
society hospital
8
telepharmacy scopes
8
guide
6

Similar Publications

Daidzein improves muscle atrophy caused by lovastatin by regulating the AMPK/FOXO3a axis.

Chin Med

December 2024

State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

Background: Lovastatin, the main lipid-lowering component in red yeast rice, is a golden anti-lipid drug, but its long-term application is continuously challenged by potential skeletal muscle atrophy. Daidzein, an isoflavone derived from soybeans and many Chinese medicines, shows therapeutic potential in treating muscle-related diseases and metabolic disorders. However, whether daidzein can improve lovastatin-induced muscle atrophy and the specific mechanism needs to further study.

View Article and Find Full Text PDF

Background: Patient-derived organoids (PDOs) represent a promising approach for replicating the characteristics of original tumors and facilitating drug testing for personalized treatments across diverse cancer types. However, clinical evidence regarding their application to esophageal cancer remains limited. This study aims to evaluate the efficacy of implementing PDOs in clinical practice to benefit patients with esophageal squamous cell carcinoma (ESCC).

View Article and Find Full Text PDF

Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: a retrospective focused pharmacovigilance study.

BMC Ophthalmol

December 2024

Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.

Background: Prostaglandin analogs are first-line treatments for open-angle glaucoma due to their proven efficacy in reducing intraocular pressure. Despite their topical administration, systemic adverse drug Events (ADEs) have been reported. This study investigates the systemic ADEs associated with topical prostaglandin analogs using the United States Food and Drug Administration (USFDA) Adverse Drug Event Reporting System (AERS) database.

View Article and Find Full Text PDF

Introduction: Ineffective coordination during care transitions from hospitals to skilled nursing facilities (SNFs) costs Medicare US$2.8-US$3.4 billion annually and results in avoidable adverse events.

View Article and Find Full Text PDF

Background/aim: The use of hypnotic drugs can lead to accidents and injuries. However, few reports have shown their association with these events after adjusting for many concomitant medications. This study aimed to determine whether the use of hypnotic drugs was associated with accidents and injuries.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!